Adam H. Schechter has served as a director of the Company since April 2013, President and Chief Executive Officer of the Company since November 2019, and Chairman of the Board since May 2020. Prior to that, Mr. Schechter was President of Global Human Health and an Executive Vice President of Merck & Co., Inc., a pharmaceutical company, from 2010 to 2018, where he was a member of Merck s executive committee. He served as special advisor to the CEO of Merck from January 2019 to July 2019. Prior to becoming President, Global Human Health, Mr. Schechter served as President, Global Pharmaceutical Business from 2007 to 2010. Mr. Schechter holds a bachelor s degree in biology from La Salle University and was awarded an honorary Doctor of Humane Letters degree from La Salle University in 2021. Skills and Qualifications: Global and U.S.-focused leadership roles, while at Merck, spanning sales, marketing, and managed markets, as well as business and product development Deep knowledge of the pharmaceutical and healthcare industries and extensive experience collaborating with many of the industries key stakeholders to achieve patient-focused outcomes CERT Certificate in Cybersecurity Oversight Current Public Company Board Experience: DaVita Inc. Other Current Relevant Experience: Vice Chair of the Board of Directors for the American Clinical Laboratory Association La Salle University, Board of Trustees Member, Academic Affairs Committee Member and Mission and Identity Committee Member Corporate Advisory Council for the National Alliance for Hispanic Health Project HOPE, Board Member Water.org, Board Member Business Strategy Corporate Finance and M&A Corporate Governance Executive Leadership Healthcare/ Clinical Research International Risk Management Sales and Marketing Talent Management Technology/ Cybersecurity